The rising interest in effective weight management has resulted in considerable exploration into novel treatments. Lately , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist , has demonstrated encouraging results in clinical trials, implying potential for significant w